Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15722 | 696 | 43.7 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
3037 | 2 | KLF4//KRUPPEL LIKE FACTOR//GADD45 | 2468 |
15722 | 1 | MITHRAMYCIN//SP1//TOLFENAMIC ACID | 696 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MITHRAMYCIN | authKW | 760212 | 5% | 47% | 37 |
2 | SP1 | authKW | 494420 | 17% | 9% | 119 |
3 | TOLFENAMIC ACID | authKW | 342710 | 4% | 31% | 25 |
4 | AUREOLIC ACID | authKW | 296127 | 1% | 75% | 9 |
5 | SPECIFICITY PROTEIN 1 | authKW | 274168 | 3% | 31% | 20 |
6 | SP3 | authKW | 229152 | 5% | 16% | 32 |
7 | SP TRANSCRIPTION FACTORS | authKW | 225610 | 2% | 43% | 12 |
8 | SP PROTEINS | authKW | 175481 | 1% | 67% | 6 |
9 | MITHRAMYCIN A | authKW | 136664 | 1% | 35% | 9 |
10 | OLIVOMYCIN A | authKW | 131614 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 2111 | 46% | 0% | 323 |
2 | Oncology | 917 | 20% | 0% | 141 |
3 | Cell Biology | 710 | 18% | 0% | 124 |
4 | Biophysics | 274 | 8% | 0% | 57 |
5 | Genetics & Heredity | 189 | 8% | 0% | 57 |
6 | Pharmacology & Pharmacy | 97 | 9% | 0% | 66 |
7 | Chemistry, Medicinal | 84 | 4% | 0% | 28 |
8 | Developmental Biology | 64 | 2% | 0% | 16 |
9 | Biotechnology & Applied Microbiology | 11 | 3% | 0% | 23 |
10 | Neurosciences | 11 | 5% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSLAT ANIM | 131614 | 0% | 100% | 3 |
2 | VET PHYSIOL TOXICOL | 87743 | 0% | 100% | 2 |
3 | VET PHYSIOL PHARMACOL | 84683 | 6% | 5% | 42 |
4 | BIOL FUNDAMENTAL CIENCIES SALUT | 65804 | 0% | 50% | 3 |
5 | BIOL FUNC | 45160 | 3% | 4% | 24 |
6 | 4 BIOQUIM BIOL MOL | 43871 | 0% | 100% | 1 |
7 | 4 PHARM | 43871 | 0% | 100% | 1 |
8 | BEREICH WIRKSTOFFE | 43871 | 0% | 100% | 1 |
9 | BIOCHEM MOL BIOLBK21 PROJECT MED SCI | 43871 | 0% | 100% | 1 |
10 | BIOCHEM MOL BIOLSEODAEMOON KU | 43871 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 1287 | 2% | 0% | 11 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 805 | 8% | 0% | 55 |
3 | BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 662 | 1% | 0% | 4 |
4 | JOURNAL OF ANTIBIOTICS | 642 | 1% | 0% | 10 |
5 | BIOCHEMISTRY | 603 | 4% | 0% | 28 |
6 | NUCLEIC ACIDS RESEARCH | 503 | 3% | 0% | 22 |
7 | GENE | 485 | 2% | 0% | 15 |
8 | JOURNAL OF INORGANIC BIOCHEMISTRY | 370 | 1% | 0% | 7 |
9 | FEBS OPEN BIO | 369 | 0% | 0% | 2 |
10 | PHARMACOLOGY & TOXICOLOGY | 291 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MITHRAMYCIN | 760212 | 5% | 47% | 37 | Search MITHRAMYCIN | Search MITHRAMYCIN |
2 | SP1 | 494420 | 17% | 9% | 119 | Search SP1 | Search SP1 |
3 | TOLFENAMIC ACID | 342710 | 4% | 31% | 25 | Search TOLFENAMIC+ACID | Search TOLFENAMIC+ACID |
4 | AUREOLIC ACID | 296127 | 1% | 75% | 9 | Search AUREOLIC+ACID | Search AUREOLIC+ACID |
5 | SPECIFICITY PROTEIN 1 | 274168 | 3% | 31% | 20 | Search SPECIFICITY+PROTEIN+1 | Search SPECIFICITY+PROTEIN+1 |
6 | SP3 | 229152 | 5% | 16% | 32 | Search SP3 | Search SP3 |
7 | SP TRANSCRIPTION FACTORS | 225610 | 2% | 43% | 12 | Search SP+TRANSCRIPTION+FACTORS | Search SP+TRANSCRIPTION+FACTORS |
8 | SP PROTEINS | 175481 | 1% | 67% | 6 | Search SP+PROTEINS | Search SP+PROTEINS |
9 | MITHRAMYCIN A | 136664 | 1% | 35% | 9 | Search MITHRAMYCIN+A | Search MITHRAMYCIN+A |
10 | OLIVOMYCIN A | 131614 | 0% | 100% | 3 | Search OLIVOMYCIN+A | Search OLIVOMYCIN+A |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VIZCAINO, C , MANSILLA, S , PORTUGAL, J , (2015) SP1 TRANSCRIPTION FACTOR: A LONG-STANDING TARGET IN CANCER CHEMOTHERAPY.PHARMACOLOGY & THERAPEUTICS. VOL. 152. ISSUE . P. 111 -124 | 105 | 61% | 17 |
2 | SAFE, S , IMANIRAD, P , SREEVALSAN, S , NAIR, V , JUTOORU, I , (2014) TRANSCRIPTION FACTOR SP1, ALSO KNOWN AS SPECIFICITY PROTEIN 1 AS A THERAPEUTIC TARGET.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 18. ISSUE 7. P. 759 -769 | 58 | 60% | 19 |
3 | BEISHLINE, K , AZIZKHAN-CLIFFORD, J , (2015) SP1 AND THE 'HALLMARKS OF CANCER'.FEBS JOURNAL. VOL. 282. ISSUE 2. P. 224 -258 | 72 | 20% | 38 |
4 | BOSSERMAN, MA , FLOREZ, AB , SHAABAN, KA , BRANA, AF , SALAS, JA , MENDEZ, C , ROHR, J , (2011) CHARACTERIZATION OF THE TERMINAL ACTIVATION STEP CATALYZED BY OXYGENASE CMMOIV OF THE CHROMOMYCIN BIOSYNTHETIC PATHWAY FROM STREPTOMYCES GRISEUS.BIOCHEMISTRY. VOL. 50. ISSUE 8. P. 1421-1428 | 26 | 84% | 2 |
5 | BARCELO, F , ORTIZ-LOMBARDIA, M , MARTORELL, M , OLIVER, M , MENDEZ, C , SALAS, JA , PORTUGAL, J , (2010) DNA BINDING CHARACTERISTICS OF MITHRAMYCIN AND CHROMOMYCIN ANALOGUES OBTAINED BY COMBINATORIAL BIOSYNTHESIS.BIOCHEMISTRY. VOL. 49. ISSUE 49. P. 10543-10552 | 31 | 67% | 19 |
6 | NUNEZ, LE , NYBO, SE , GONZALEZ-SABIN, J , PEREZ, M , MENENDEZ, N , BRANA, AF , SHAABAN, KA , HE, M , MORIS, F , SALAS, JA , ET AL (2012) A NOVEL MITHRAMYCIN ANALOGUE WITH HIGH ANTITUMOR ACTIVITY AND LESS TOXICITY GENERATED BY COMBINATORIAL BIOSYNTHESIS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 12. P. 5813 -5825 | 30 | 64% | 14 |
7 | FERNANDEZ-GUIZAN, A , MANSILLA, S , BARCELO, F , VIZCAINO, C , NUNEZ, LE , MORIS, F , GONZALEZ, S , PORTUGAL, J , (2014) THE ACTIVITY OF A NOVEL MITHRAMYCIN ANALOG IS RELATED TO ITS BINDING TO DNA, CELLULAR ACCUMULATION, AND INHIBITION OF SP1-DRIVEN GENE TRANSCRIPTION.CHEMICO-BIOLOGICAL INTERACTIONS. VOL. 219. ISSUE . P. 123 -132 | 25 | 74% | 3 |
8 | BOUWMAN, P , PHILIPSEN, S , (2002) REGULATION OF THE ACTIVITY OF SP1-RELATED TRANSCRIPTION FACTORS.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 195. ISSUE 1-2. P. 27 -38 | 47 | 38% | 331 |
9 | MENDEZ, C , GONZALEZ-SABIN, J , MORIS, F , SALAS, JA , (2015) EXPANDING THE CHEMICAL DIVERSITY OF THE ANTITUMORAL COMPOUND MITHRAMYCIN BY COMBINATORIAL BIOSYNTHESIS AND BIOCATALYSIS: THE QUEST FOR MITHRALOGS WITH IMPROVED THERAPEUTIC WINDOW.PLANTA MEDICA. VOL. 81. ISSUE 15. P. 1326 -1338 | 32 | 55% | 2 |
10 | TEVYASHOVA, AN , DURANDIN, NA , VINOGRADOV, AM , ZBARSKY, VB , REZNIKOVA, MI , DEZHENKOVA, LG , BYKOV, EE , OLSUFYEVA, EN , KUZMIN, VA , SHTIL, AA , ET AL (2013) ROLE OF THE ACYL GROUPS IN CARBOHYDRATE CHAINS IN CYTOTOXIC PROPERTIES OF OLIVOMYCIN A.JOURNAL OF ANTIBIOTICS. VOL. 66. ISSUE 9. P. 523 -530 | 20 | 91% | 2 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 8864 | KLF4//KRUPPEL LIKE FACTOR//KLF5 |
2 | 36462 | ZBP 89//ZNF148//BAK GENES |
3 | 36295 | MIR 335//MICRORNA 335//B CELL CLL LYMPHOMA 2 LIKE 2 |
4 | 32339 | HIRANO BODIES//TMEM132A//INTRANEURONAL INCLUSIONS |
5 | 34666 | ZNF703//C8ORF4//THYROID CANCER 1 |
6 | 11917 | 2 DEOXYGLYCOSIDES//VANCOSAMINE//2 6 ANHYDRO 2 THIO SUGAR |
7 | 26432 | YY1//YIN YANG 1//YY2 |
8 | 11799 | GLMU//BIOSYNTHET CHEM//DEOXYSUGARS |
9 | 20943 | NF Y//CCAAT BOX//NF YB |
10 | 9157 | SABARUBICIN//BARMINOMYCIN//ACTINOMYCIN |